Yarom, Noam http://orcid.org/0000-0001-9771-7857
Hovan, Allan
Bossi, Paolo
Ariyawardana, Anura
Jensen, Siri Beier
Gobbo, Margherita
Saca-Hazboun, Hanan
kandwal, Abhishek
Majorana, Alessandra
Ottaviani, Giulia
Pentenero, Monica
Nasr, Narmin Mohammed
Rouleau, Tanya
Lucas, Anna Skripnik
Treister, Nathaniel Simon
Zur, Eyal
Ranna, Vinisha
Vaddi, Anusha
Cheng, Karis Kin Fong
Barasch, Andrei
Lalla, Rajesh V.
Elad, Sharon
,
Article History
Received: 26 January 2019
Accepted: 22 May 2019
First Online: 8 July 2019
Change Date: 24 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00520-021-06141-9
Compliance with ethical standards
:
: Per the MASCC Guidelines Policy, employees of commercial entities were not eligible to serve on this MASCC Guidelines Panel.The authors disclose no conflict of interest (NY, AH, AA, SBJ, MG, HIH, AK, AM, GO, MP, NMN, TR, ASL, NST, EZ, VR, AV, KF, AB, SE). PB has served an advisory role for AstraZeneca, Helsinn, and Kyowa Kyrin and received grants from Merck, Kyowa Kyrin, and Roche.RVL has served as a consultant for Colgate Oral Pharmaceuticals, Galera Therapeutics, Ingalfarma SA, Monopar Therapeutics, Mundipharma, and Sucampo Pharma; has received research support to his institution from Galera Therapeutics, Novartis, Oragenics, and Sucampo Pharma; and has received stock in Logic Biosciences.